Setchell KD - Search Results

1

Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.

Crosignani A, Podda M, Battezzati PM, Bertolini E, Zuin M, Watson D, Setchell KD. Crosignani A, et al. Among authors: setchell kd. Hepatology. 1991 Dec;14(6):1000-7. Hepatology. 1991. PMID: 1959845

2

Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study.

Colombo C, Crosignani A, Assaisso M, Battezzati PM, Podda M, Giunta A, Zimmer-Nechemias L, Setchell KD. Colombo C, et al. Among authors: setchell kd. Hepatology. 1992 Oct;16(4):924-30. doi: 10.1002/hep.1840160412. Hepatology. 1992. PMID: 1398498 Clinical Trial.

3

Analysis of vitamin D and its metabolites using thermospray liquid chromatography/mass spectrometry.

Watson D, Setchell KD, Ross R. Watson D, et al. Among authors: setchell kd. Biomed Chromatogr. 1991 Jul;5(4):153-60. doi: 10.1002/bmc.1130050404. Biomed Chromatogr. 1991. PMID: 1655127

4

Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study.

Crosignani A, Battezzati PM, Setchell KD, Camisasca M, Bertolini E, Roda A, Zuin M, Podda M. Crosignani A, et al. Among authors: setchell kd. Hepatology. 1991 Feb;13(2):339-44. Hepatology. 1991. PMID: 1671665 Clinical Trial.

5

Oral bile acid treatment and the patient with Zellweger syndrome.

Setchell KD, Bragetti P, Zimmer-Nechemias L, Daugherty C, Pelli MA, Vaccaro R, Gentili G, Distrutti E, Dozzini G, Morelli A, et al. Setchell KD, et al. Hepatology. 1992 Feb;15(2):198-207. doi: 10.1002/hep.1840150206. Hepatology. 1992. PMID: 1735522

6

Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.

Crosignani A, Podda M, Bertolini E, Battezzati PM, Zuin M, Setchell KD. Crosignani A, et al. Among authors: setchell kd. Hepatology. 1991 Jun;13(6):1076-83. Hepatology. 1991. PMID: 2050325

7

Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.

Nakagawa M, Colombo C, Setchell KD. Nakagawa M, et al. Among authors: setchell kd. Hepatology. 1990 Aug;12(2):322-34. doi: 10.1002/hep.1840120221. Hepatology. 1990. PMID: 2391071

8

Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.

Colombo C, Setchell KD, Podda M, Crosignani A, Roda A, Curcio L, Ronchi M, Giunta A. Colombo C, et al. Among authors: setchell kd. J Pediatr. 1990 Sep;117(3):482-9. doi: 10.1016/s0022-3476(05)81103-5. J Pediatr. 1990. PMID: 2391610

9

Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.

Hillaire S, Ballet F, Franco D, Setchell KD, Poupon R. Hillaire S, et al. Among authors: setchell kd. Hepatology. 1995 Jul;22(1):82-7. Hepatology. 1995. PMID: 7601437

10

Metabolism and effect of 7-oxo-lithocholic acid 3-sulfate on bile flow and biliary lipid secretion in rats.

Yamashita H, Setchell KD. Yamashita H, et al. Among authors: setchell kd. Hepatology. 1994 Sep;20(3):663-71. Hepatology. 1994. PMID: 8076924

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters